Scemblix (asciminib) is a new first-line option for adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP). Novartis announced yesterday ...

Proposed B-BBEE Transaction - Distribution of Circular, Notice of General Meeting and Salient Dates and Times CORONATION FUND MANAGERS LIMITED (Incorporated in the Republic of South Africa) ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Scemblix, a new first-line option for adults with CML, is first to show superior efficacy and favorable safety and tolerability profile in a Phase III trial vs. all standard of care (SoC) therapies ...

The ASC4FIRST trial has shown asciminib, a novel BCR::ABL1 inhibitor, as a promising alternative to current tyrosine kinase inhibitors (TKIs) for chronic phase (CP) chronic myeloid leukaemia (CML).

This paper evaluates the integration of CMLs into power grids, focusing on distribution network performance. A technology-accepted model for assessing cryptocurrency mining performance is presented, ...

Financial Services Secretary M Nagaraju, who was also present at the ceremony, expressed his happiness with the bank's initiative.

Join the CML Book Club! The CTV Morning Live hosts will share a new title each month. Read along, share your thoughts, and recommend your favourite books. The CML Book Club’s first selection is ...

The author and editors take ultimate responsibility for the content. Wholesale distributors work behind the scenes, occupying a vital space in the supply chain between manufacturers and retailers.

Your small business can choose from a variety of distribution channels, all of which can affect your target market, product, price and reputation. You may need to experiment with a mix of distribution ...